Early diagnosis

A confirmed neuromuscular diagnosis is key to better health outcomes and improved quality of life.

Why it matters

How we support early diagnosis

"When my son needed surgery, genetic testing gave us a confirmed diagnosis that empowered me advocate for his care – a confidence that may have saved his life."

Teresa Buffone, parent to a child living with myotonic dystrophy 

Icon of a megaphone.

Harmonized newborn screening for Spinal Muscular Atrophy (SMA), nationwide: We successfully advocated for SMA testing to be included in newborn screening panels in every province and territory in Canada.

Icon of a megaphone.

No-cost genetic testing for mytonic dystrophy: We are facilitating no-cost genetic testing for people suspected of having myotonic dystrophy, providing a critical pathway to early and more accurate diagnosis.

Your questions, answered!

Would you like to learn more about options for early diagnosis of a suspected neuromuscular disorder? We can help! Call or email our Research Hotline to learn more.
A young mother cradles her newborn baby who is swaddled in a grey blanket.

Your questions, answered!

Would you like to learn more about options for early diagnosis of a suspected neuromuscular disorder? We can help! Call or email our Research Hotline to learn more.

"Ensuring access to timely and accurate diagnoses is essential for unlocking opportunities like clinical trials that hold so much promise and give everyone a chance at better outcomes.”

The LeBoeuf family, affected by myotonic dystrophy

Support for infants with SMA

If your baby received an SMA diagnosis through newborn screening, SMArTrack is here to support you. Contact our Research Hotline to learn more or get involved.